Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Insulin resistance: an additional risk factor in the pathogenesis of cardiovascular disease in type 2 diabetes
Tushar Patel, Komal Rawal, Ashim K. Bagchi, et al.
Heart Failure Reviews (2015) Vol. 21, Iss. 1, pp. 11-23
Closed Access | Times Cited: 207

Showing 1-25 of 207 citing articles:

The relationship between obesity and cognitive health and decline
Louise Dye, Neil Bernard Boyle, Claire Champ, et al.
Proceedings of The Nutrition Society (2017) Vol. 76, Iss. 4, pp. 443-454
Open Access | Times Cited: 364
Diagnostic Accuracy of the Triglyceride and Glucose Index for Insulin Resistance: A Systematic Review
Adriana Sánchez‐García, René Rodríguez‐Gutiérrez, Leonardo Mancillas‐Adame, et al.
International Journal of Endocrinology (2020) Vol. 2020, pp. 1-7
Open Access | Times Cited: 314
Short-chain fatty acid, acylation and cardiovascular diseases
Xiaofeng Chen, Xiangqi Chen, Xiaoqiang Tang
Clinical Science (2020) Vol. 134, Iss. 6, pp. 657-676
Closed Access | Times Cited: 149
Association between the triglyceride glucose-body mass index and future cardiovascular disease risk in a population with Cardiovascular-Kidney-Metabolic syndrome stage 0–3: a nationwide prospective cohort study
Weipeng Li, Chaonan Shen, Weiya Kong, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 27
Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy
Mariël F. van Stee, Albert A. de Graaf, Albert K. Groen
Cardiovascular Diabetology (2018) Vol. 17, Iss. 1
Open Access | Times Cited: 126
Metabolic Syndrome as a Multifaceted Risk Factor for Oxidative Stress
Schohraya Spahis, Jean-Michel Borys, Émile Lévy
Antioxidants and Redox Signaling (2016) Vol. 26, Iss. 9, pp. 445-461
Closed Access | Times Cited: 121
The Protective Effect of Antioxidants Consumption on Diabetes and Vascular Complications
Stéphanie Dal, S. Sigrist
Diseases (2016) Vol. 4, Iss. 3, pp. 24-24
Open Access | Times Cited: 99
The Role of Protein Tyrosine Phosphatase (PTP)-1B in Cardiovascular Disease and Its Interplay with Insulin Resistance
Shahenda S. Abdelsalam, Hesham M. Korashy, Asad Zeidan, et al.
Biomolecules (2019) Vol. 9, Iss. 7, pp. 286-286
Open Access | Times Cited: 98
International Union of Basic and Clinical Pharmacology. CVII. Structure and Pharmacology of the Apelin Receptor with a Recommendation that Elabela/Toddler Is a Second Endogenous Peptide Ligand
Cai Read, Duuamene Nyimanu, Thomas Williams, et al.
Pharmacological Reviews (2019) Vol. 71, Iss. 4, pp. 467-502
Open Access | Times Cited: 97
<p>Nanoformulations of natural products for management of metabolic syndrome</p>
Yasamin Davatgaran Taghipour, Marziyeh Hajialyani, Rozita Naseri, et al.
International Journal of Nanomedicine (2019) Vol. Volume 14, pp. 5303-5321
Open Access | Times Cited: 94
Insulin resistance, diabetic kidney disease, and all-cause mortality in individuals with type 2 diabetes: a prospective cohort study
Giuseppe Penno, Anna Solini, Emanuela Orsi, et al.
BMC Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 91
The effects of vitamin D and probiotic co-supplementation on mental health parameters and metabolic status in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial
Fariba Raygan, Vahidreza Ostadmohammadi, Fereshteh Bahmani, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2018) Vol. 84, pp. 50-55
Closed Access | Times Cited: 89
Efficacy of dapagliflozin versus sitagliptin on cardiometabolic risk factors in Japanese patients with type 2 diabetes: a prospective, randomized study (DIVERSITY-CVR)
Ayako Fuchigami, Fumika Shigiyama, Toru Kitazawa, et al.
Cardiovascular Diabetology (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 82
Mulberry leaf (Morus alba L.): A review of its potential influences in mechanisms of action on metabolic diseases
Ruiyuan Zhang, Zhang Qian, Shun Zhu, et al.
Pharmacological Research (2021) Vol. 175, pp. 106029-106029
Closed Access | Times Cited: 79
<p>Hypertension and Its Associated Factors Among Type 2 Diabetes Mellitus Patients at Debre Tabor General Hospital, Northwest Ethiopia</p>
Yonas Akalu, Yitayeh Belsti
Diabetes Metabolic Syndrome and Obesity (2020) Vol. Volume 13, pp. 1621-1631
Open Access | Times Cited: 78
NAFLD and Cardiovascular Diseases: Epidemiological, Mechanistic and Therapeutic Considerations
David Niederseer, Bernhard Wernly, Elmar Aigner, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 3, pp. 467-467
Open Access | Times Cited: 61
Effect of Intermittent Fasting Diet on Glucose and Lipid Metabolism and Insulin Resistance in Patients with Impaired Glucose and Lipid Metabolism: A Systematic Review and Meta-Analysis
Xiaojie Yuan, Jiping Wang, Shuo Yang, et al.
International Journal of Endocrinology (2022) Vol. 2022, pp. 1-9
Open Access | Times Cited: 55
Inflammation and Insulin Resistance in Diabetic Chronic Coronary Syndrome Patients
Tianyu Li, Peizhi Wang, Xiaozeng Wang, et al.
Nutrients (2023) Vol. 15, Iss. 12, pp. 2808-2808
Open Access | Times Cited: 35
Cardiometabolic Risk Factors Associated With Type 2 Diabetes Mellitus: A Mechanistic Insight
Snigdha Chakraborty, Anjali Verma, Rajeev Garg, et al.
Clinical Medicine Insights Endocrinology and Diabetes (2023) Vol. 16
Open Access | Times Cited: 27
The role of glycolytic metabolic pathways in cardiovascular disease and potential therapeutic approaches
Shuxian Chen, Yuanming Zou, Chunyu Song, et al.
Basic Research in Cardiology (2023) Vol. 118, Iss. 1
Open Access | Times Cited: 23
A Narrative Review of Diabetic Macroangiopathy: From Molecular Mechanism to Therapeutic Approaches
Jiacheng Yin, Xiaoxu Fu, Yue Luo, et al.
Diabetes Therapy (2024) Vol. 15, Iss. 3, pp. 585-609
Open Access | Times Cited: 8
Exosomal Mst1 transfer from cardiac microvascular endothelial cells to cardiomyocytes deteriorates diabetic cardiomyopathy
Jianqiang Hu, Shanjie Wang, Zhenyu Xiong, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2018) Vol. 1864, Iss. 11, pp. 3639-3649
Closed Access | Times Cited: 80
IL-1 family cytokines in cardiovascular disease
Susanne Pfeiler, Holger Winkels, Malte Kelm, et al.
Cytokine (2017) Vol. 122, pp. 154215-154215
Closed Access | Times Cited: 75
Prebiotics in the management of components of the metabolic syndrome
Sarah O’Connor, Sarah Chouinard-Castonguay, Claudia Gagnon, et al.
Maturitas (2017) Vol. 104, pp. 11-18
Closed Access | Times Cited: 73
Risk of skin cancer in patients with diabetes mellitus
Hui‐Wen Tseng, Yow‐Ling Shiue, Kuo‐Wang Tsai, et al.
Medicine (2016) Vol. 95, Iss. 26, pp. e4070-e4070
Open Access | Times Cited: 72
Page 1 - Next Page

Scroll to top